Henry Schein

Henry Schein, Inc. engages in the provision of health care products and services to medical, dental, and veterinary office-based practitioners. It operates through the Healthcare Distribution, and Technology and Value-Added Services segments. The Healthcare Distribution segment includes consumable products, laboratory, small and large equipment repair services, branded and generic pharmaceuticals, vaccines, surgicals, diagnostic tests, infection-control products and vitamins. The Technology & Value-Added Services segment offers financial on a non-recourse basis, network and hardware services. The company was founded by Henry Schein and Esther Schein in 1932 and is headquartered in Melville, NY.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Henry Schein reports solid Q4 performance and anticipates growth

Henry Schein's Q4 performance showcased growth amidst challenges, with a strategic focus on core margin expansion and strong performance in dental specialties. While facing challenges from declining PPE sales and supply chain issues, the company sees opportunities in stable dental markets and continued growth in operating income. Overall, the company remains optimistic about its outlook for 2023.

Henry Schein reports strong Q1 earnings, eyes growth through acquisitions

Henry Schein's Q1 2023 earnings call highlighted strong financial performance across its dental, medical, and Technology and Value-Added Services businesses. While facing challenges from declining PPE and COVID-19 test kit sales, the company remains optimistic about growth opportunities through acquisitions and stable business segments.

Henry Schein reports solid Q2 results, eyes growth opportunities

Henry Schein's Q2 performance was driven by strong dental sales, while facing challenges from declining PPE and COVID test kit sales. The company is focused on strategic acquisitions and expanding product offerings, with opportunities in technology and specialty products driving growth.

Henry Schein navigates post-cyber incident challenges, focuses on recovery

Henry Schein faced challenges from a cybersecurity incident impacting operations but showcased resilience and recovery efforts across its business segments.
Strategic initiatives focused on customer retention, operational efficiency, and cybersecurity response highlight the company's commitment to long-term growth and stability.
Despite challenges in specific segments and cybersecurity spending variables, Henry Schein's focus on recovery, cost-cutting, and customer trust positions it for future opportunities.
The company's emphasis on digital channels, stable medical demand, and strategic cost-cutting measures underscores its adaptability and strategic vision for sustained growth.

Henry Schein reports resilient Q4 performance and outlines 2024 guidance

Henry Schein's Q4 2023 performance reflects resilience amidst challenges, with a strategic focus on technology, global sales, and recovery post-cyber incident. The company's 2024 outlook includes managing residual cyber impacts and pursuing growth opportunities.

Henry Schein reports solid Q1 earnings, eyes market share expansion

Henry Schein's Q1 performance reflects resilience and growth across key segments, with a focus on market share expansion and profitability. While facing challenges in dental consumables and pricing stability, the company is leveraging opportunities in product portfolio expansion and market positioning. Strategic acquisitions and recovery efforts post-cyber incident are driving competitive strength and customer loyalty.

Henry Schein reports mixed Q2 performance, focuses on cost savings

Henry Schein navigated challenges from a cyber incident, with mixed performance across segments in Q2 2024.
Strong sales growth in dental specialties, focus on cost savings, and resilience in technology services were highlights.
The company's strategic initiatives, financial guidance update, and confidence in future prospects were key takeaways from the call.

Henry Schein excels in Q3 with strategic growth initiatives

Henry Schein's Q3 performance reflects strong market positioning and strategic execution, driving growth across key business segments.
While facing challenges such as LCI sales decline, the company's focus on operational efficiency and cost management remains a priority.
With increased sales guidance, ongoing restructuring initiatives, and strategic capital allocation plans, Henry Schein is poised for continued success and expansion.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Henry Schein, Inc. engages in the provision of health care products and services to medical, dental, and veterinary office-based practitioners. It operates through the Healthcare Distribution and Technology and Value-Added Services segments. The Healthcare Distribution segment includes consumable products, laboratory, small and large equipment repair services, branded and generic pharmaceuticals, vaccines, surgical, diagnostic tests, infection-control products, and vitamins. The Technology and Value-Added Services segment offers financial on a non-recourse basis, network, and hardware services. The company was founded by Henry Schein and Esther Schein in 1932 and is headquartered in Melville, NY.

According to Henry Schein (HSIC), the upper and lower extremities are among the fastest-growing segments of orthopedics, representing a total addressable market of more than $5.5 billion.

Henry Schein (HSIC) Buys TriMed to Expand in Orthopedic Space

MELVILLE, N.Y.--(BUSINESS WIRE)--Henry Schein completes acquisition of majority interest of TriMed, Inc.

Henry Schein Completes Acquisition of Majority Interest of TriMed, Inc.

MELVILLE, N.Y.--(BUSINESS WIRE)--Henry Schein, Inc. (Nasdaq: HSIC) announced today that it will host THRIVELIVE™ 2024, the Company's annual dental event that celebrates innovation and community and provides a one-of-a-kind educational experience for dental professionals to learn how to grow their practices. This year's THRIVELIVE will take place at the Bellagio in Las Vegas, Nevada, from May 2-4, 2024. For the fourth consecutive year, THRIVELIVE will offer a comprehensive program designed to em.

Henry Schein Presents THRIVELIVE 2024

Henry Schein (HSIC) reported earnings 30 days ago. What's next for the stock?

Why Is Henry Schein (HSIC) Down 1.8% Since Last Earnings Report?

MELVILLE, N.Y.--(BUSINESS WIRE)--Henry Schein, Inc. (Nasdaq: HSIC), the world's largest provider of health care solutions to office-based dental and medical practitioners, has received the 2024 World's Most Ethical Companies® recognition by Ethisphere, a global leader in defining and advancing the standards of ethical business practices. Henry Schein has been recognized since 2012 and is one of only two honorees in the Healthcare Products industry. In 2024, 136 honorees were recognized spanning.

Ethisphere Names Henry Schein as One of the 2024 World's Most Ethical Companies® for 13th Consecutive Year

Henry Schein, Inc. (HSIC) Q4 2023 Earnings Call Transcript

While the top- and bottom-line numbers for Henry Schein (HSIC) give a sense of how the business performed in the quarter ended December 2023, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

Compared to Estimates, Henry Schein (HSIC) Q4 Earnings: A Look at Key Metrics

Henry Schein (HSIC) posts lower-than-expected earnings and revenues in the fourth quarter of 2023.

Henry Schein (HSIC) Q4 Earnings Miss, Operating Margin Down

Henry Schein (HSIC) came out with quarterly earnings of $0.66 per share, missing the Zacks Consensus Estimate of $0.70 per share. This compares to earnings of $1.21 per share a year ago.

Henry Schein (HSIC) Lags Q4 Earnings and Revenue Estimates

MELVILLE, N.Y.--(BUSINESS WIRE)--Henry Schein reports fourth-quarter and full-year 2023 financial results and introduces 2024 financial guidance.

Henry Schein Reports Fourth-Quarter and Full-Year 2023 Financial Results and Introduces 2024 Financial Guidance

Besides Wall Street's top -and-bottom-line estimates for Henry Schein (HSIC), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended December 2023.

Seeking Clues to Henry Schein (HSIC) Q4 Earnings? A Peek Into Wall Street Projections for Key Metrics

MELVILLE, N.Y.--(BUSINESS WIRE)--In celebration of National Athletic Training Month in March, Henry Schein Medical, the U.S. medical business of Henry Schein, Inc. (Nasdaq: HSIC), is now accepting nominations for its Henry Schein Medical Athletics and Schools 2024 Rising Star Award. Created in 2021, the annual Award honors emerging athletic trainers with one to five years of experience in the sports medicine industry. It recognizes recently graduated athletic trainers in the United States who h.

Nominations Now Open for Henry Schein Medical's Athletics and Schools 2024 Rising Star Award

MELVILLE, N.Y.--(BUSINESS WIRE)--Henry Schein, National Dental Association and Schattner Foundation present Student Mentoring Program for Aspiring Dental Professionals.

Henry Schein, National Dental Association and Schattner Foundation Present Student Mentoring Program for Aspiring Dental Professionals

MELVILLE, N.Y.--(BUSINESS WIRE)--Henry Schein, Inc. (Nasdaq: HSIC) today announced it will present at the 2024 Chicago Dental Society Midwinter Meeting a comprehensive lineup of digital equipment, technology solutions, and business services designed to help dental practices operate more efficiently and effectively. The Midwinter Meeting, which is scheduled for February 22 to February 24, 2024, will provide practitioners an opportunity to experience an immersive display of Henry Schein's extensi.

Henry Schein Presents a Comprehensive Lineup of Solutions at the 2024 Chicago Dental Society Midwinter Meeting

Henry Schein's (HSIC) fourth-quarter 2023 results are likely to reflect the resiliency of the dental and medical markets amid macroeconomic challenges.

Henry Schein (HSIC) Set to Post Q4 Earnings: What Awaits?

MELVILLE, N.Y.--(BUSINESS WIRE)--Henry Schein, Inc. (Nasdaq: HSIC) today announced the launch of Prevention is Power™, a multi-year public health awareness campaign from the Henry Schein Cares Foundation, Inc. (HSCF) to help improve health literacy and strengthen patient utilization of integrated, preventive care, with the goal of reducing incidences of chronic diseases as well as overall health care spending. HSCF is a philanthropic vehicle that advocates and supports efforts to advance health.

Henry Schein Cares Foundation Launches ‘Prevention is Power' Public Health Awareness Campaign

MELVILLE, N.Y.--(BUSINESS WIRE)--Henry Schein Medical, the U.S. medical business of Henry Schein, Inc. (Nasdaq: HSIC), in collaboration with the National Basketball Athletic Trainers Association, is marking National Girls and Women in Sports Day today with this video recognizing the indispensable roles played by women athletic trainers in the world of sports. Through a series of interviews, five women athletic trainers from the National Basketball Association (NBA) share how athletic trainers h.

Henry Schein Medical Champions Women Athletic Trainers During National Girls and Women in Sports Day 2024

AMERICAN FORK, Utah--(BUSINESS WIRE)--Henry Schein One Partners with 42 North Dental to Drive Innovation with Cloud Technology and AI Diagnostics.

Henry Schein One Partners with 42 North Dental to Drive Innovation with Cloud Technology and AI Diagnostics

MELVILLE, N.Y.--(BUSINESS WIRE)--Henry Schein to webcast fourth quarter and full-year 2023 conference call and introduce full-year 2024 guidance on February 27, 2024.

Henry Schein to Webcast Fourth Quarter and Full-Year 2023 Conference Call and Introduce Its Full-Year 2024 Guidance on Tuesday, February 27, 2024 at 10:00 A.M. ET

PARSIPPANY, N.J.--(BUSINESS WIRE)--Extremity Medical partners with Henry Schein, Inc. to expand its innovative orthopedic implant systems.

Extremity Medical to Expand Orthopedic Extremity Implant Systems Through Strategic Relationship With Henry Schein as Well as Growth Financings

MELVILLE, N.Y.--(BUSINESS WIRE)--Henry Schein to present at J.P. Morgan's 2024 Healthcare Investor Conference.

Henry Schein to Present at J.P. Morgan's Healthcare Investor Conference

Henry Schein's (HSIC) financial operations are being affected by the current macroeconomic environment.

Henry Schein (HSIC) Sales Hurt by Cyber Attack, Macro Woes

Henry Schein's (HSIC) recent deals will position it as a prominent producer and supplier in the orthopedic market's Foot and Ankle, Hand and Wrist extremity sectors.

Henry Schein (HSIC) Enters Orthopedic Market With New Buyout

MELVILLE, N.Y.--(BUSINESS WIRE)--Henry Schein Enters Extremity Segment of Orthopedic Market.

Henry Schein Enters Extremity Segment of Orthopedic Market

MELVILLE, N.Y.--(BUSINESS WIRE)--Henry Schein, Inc. (Nasdaq: HSIC), the world's largest provider of health care solutions to office-based dental and medical practitioners, announced today that its Board of Directors has appointed Carole T. Faig as an independent director to serve until the 2024 Annual Meeting of Stockholders in May, when she is expected to stand for re-election to the Board by a vote of the Company's stockholders. Ms. Faig brings to Henry Schein extensive expertise in finance,.

News for Henry Schein Stock (HSIC)